Ticker Details
PepGen Inc. Common Stock
IPO Date:	May 6, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$159.09M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.38 | 5.32%
Avg Daily Range (30 D):	$0.07 | 4.15%
Avg Daily Range (90 D):	$0.14 | 4.97%

Institutional Daily Volume
Avg Daily Volume:	.6M
Avg Daily Volume (30 D):	.69M
Avg Daily Volume (90 D):	1.16M

Trade Size
Avg Trade Size (Sh.):	148
Avg Trade Size (Sh.) (30 D):	179
Avg Trade Size (Sh.) (90 D):	190

Institutional Trades
Total Institutional Trades:	111
Avg Institutional Trade:	$1.69M
Avg Institutional Trade (30 D):	$1.12M
Avg Institutional Trade (90 D):	$.87M
Avg Institutional Trade Volume:	.27M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.99M
Avg Closing Trade (30 D):	$.67M
Avg Closing Trade (90 D):	$.66M
Avg Closing Volume:	361.98K

News

Apr 21, 2026 @ 8:31 AM Peptide Drug Conjugate Market Landscape Report 202... Source: Researchandmarkets.Com

Sep 25, 2025 @ 6:06 PM S&P 500 Falls 1%; Accenture Posts Upbeat Earnings Source: Avi Kapoor

Sep 25, 2025 @ 10:11 AM Why PepGen Shares Are Trading Higher By 112%; Here... Source: Avi Kapoor

Aug 7, 2025 @ 10:43 PM PEPGEN (PEPG) FINAL DEADLINE ALERT: Bragar Eagel &... Source: Bragar Eagel & Squire, P.C.

Aug 7, 2025 @ 8:00 PM PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.26	$.02	$-2.12
Diluted EPS	$-.26	$.02	$-2.12
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-17.76M	$-18.34M	$-89.66M
Operating Income / Loss	$-18.94M	$-19.71M	$-93.61M
Cost of Revenue
Net Cash Flow	$-18.37M	$-82.26M	$11.11M
PE Ratio